Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial
Author:
Paulus Kirchhof,Dietrich Andresen,Ralph Bosch,Martin Borggrefe,Thomas Meinertz,Ulli Parade,Ursula Ravens,Alexander Samol,Gerhard Steinbeck,Andras Treszl,Karl Wegscheider,Günter Breithardt
Copyright © 2012 Elsevier Ltd. All rights reserved.